These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2309318)

  • 1. Immunologic properties of a sulphate conjugate of cyclosporine A.
    Johansson A; Henricsson S; Möller E
    Transplant Proc; 1990 Feb; 22(1):213. PubMed ID: 2309318
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel sulphate conjugate of cyclosporine occurring in high concentrations in vivo.
    Johansson A; Henricsson S; Möller E
    Transplantation; 1990 Mar; 49(3):619-22. PubMed ID: 2316020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactive suppressor T cells and cytokine (gamma-IFN, interleukin 1, 2, and 3) production in cyclosporine-treated mice.
    Yoshimura N; Matsui S; Hamashima T; Oka T
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1016-24. PubMed ID: 2968691
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
    Havele C; Paetkau V
    J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunobiology of experimental lung transplantation with cyclosporine immunosuppression: cytolytic T lymphocytes and delayed type hypersensitivity in rejecting and tolerant recipients.
    Norin AJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):125-30. PubMed ID: 2966476
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
    Orosz CG; Sirinek LP; Zinn NE; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive mode of action of deoxyspergualin in mice, as compared with cyclosporine A and mizoribine.
    Okubo M; Masaki Y; Kamata K; Sato N; Inoue K; Umetani N
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1085-7. PubMed ID: 2784882
    [No Abstract]   [Full Text] [Related]  

  • 8. IL-4 bypasses the immune suppressive effect of cyclosporin A during the in vitro induction of murine cytotoxic T lymphocytes.
    Heeg K; Gillis S; Wagner H
    J Immunol; 1988 Oct; 141(7):2330-4. PubMed ID: 3262657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of T cytotoxic cells after perioperative treatment with extracted antigen and cyclosporine in rat cardiac transplantation.
    Ito T; Stepkowski S; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1045-52. PubMed ID: 3291214
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin A and the immune response to transplantation antigens.
    Hess AD
    Lymphokine Res; 1982; 1(2):23-7. PubMed ID: 6239956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and indirect modes of action of cyclosporine on cytotoxic T lymphocytes.
    Paetkau V; Havele C; Shaw J
    Ann N Y Acad Sci; 1988; 532():405-12. PubMed ID: 3052214
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic effects of cyclosporine.
    Wish JB
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):15-8. PubMed ID: 3487144
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine and unresponsiveness to allografts induced by polyclonal antilymphocyte serum and donor-specific bone marrow.
    Monaco AP; Wood ML; Maki T; Hartner W; De Fazio S; Gozzo JJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):36-48. PubMed ID: 2968700
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporin A inhibits IL 2-driven proliferation of human alloactivated T cells.
    Buurman WA; Ruers TJ; Daemen IA; van der Linden CJ; Groenewegen G
    J Immunol; 1986 Jun; 136(11):4035-9. PubMed ID: 2939138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine-induced tolerance in experimental organ transplantation. Evidence of diminished donor-specific cytotoxicity relative to donor-specific proliferative response.
    Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
    J Immunol; 1987 Jul; 139(2):332-7. PubMed ID: 2955037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal activation of cytotoxic T lymphocytes requires metabolically intact stimulator cells not only for the activation of the interleukin 2-producing helper cells.
    Dröge W; Männel D; Falk W; Schmidt H; Panknin S; Dotterer W
    J Immunol; 1983 Jul; 131(1):520-8. PubMed ID: 6223082
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity: induction and expression of T-cell function.
    Lawman MJ
    J Am Vet Med Assoc; 1982 Nov; 181(10):1022-9. PubMed ID: 6294025
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine A inhibits accessory cell and antigen-presenting cell functions of epidermal Langerhans cells.
    Furue M; Katz SI
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):87-91. PubMed ID: 3259044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.